Control Bionics Limited (ASX:CBL)
Australia
· Delayed Price · Currency is AUD 0.0290
0.00 (0.00%)
Jun 20, 2025, 4:10 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 8.54 million as of June 20, 2025. Its market cap has increased by 0.11% in one year.
Market Cap
8.54M
Enterprise Value
8.02M
Revenue
5.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 8.54M, a decrease of -91.31%. That is a compound annual growth rate of -41.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 8.54M | -43.49% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | 78.33M | -20.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.31B |
| Pro Medicus | 28.92B |
| Cochlear | 19.33B |
| Sonic Healthcare | 12.67B |
| Telix Pharmaceuticals | 8.43B |
| Ramsay Health Care | 8.29B |
| Ansell | 4.37B |
| Regis Healthcare | 2.33B |